IAG Wealth Partners’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
Other funds holding VIRX
XT
UCFA
WA
BBA
RM
IAG Wealth Partners's VIRX Position: Q1 2025 in Review
IAG Wealth Partners sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2025, closing a stake of 3,000 shares — an estimated $483 sold.
IAG Wealth Partners first reported a position in VIRX in Q2 2023 and held it in 7 quarters. The position peaked at $4.23K in Q2 2023. 7 funds tracked by Wall St. Rank hold VIRX as of Q1 2025.
- IAG Wealth Partners reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- IAG Wealth Partners sold 3,000 Viracta Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $483.
- IAG Wealth Partners first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2023 and held it in 7 quarters.
- IAG Wealth Partners's Viracta Therapeutics, Inc. Common Stock position peaked at $4.23K in Q2 2023.
- 7 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2025.
Based on IAG Wealth Partners's 13F filing for Q1 2025, filed 16 Apr 2025.